Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 526445 | NSE Symbol : | ISIN : INE007C01021 | Industry : Diversified - Medium / Small |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
27-Mar-2025	03-Apr-2025	Right Issue	Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/04/2025 inter alia to consider and approve amendments in the terms of Rights issue of equity shares of the Company Announcement with respect to the amendments to the terms of Rights issue of equity shares as partly paid up equity shares instead of fully paid up equity shares, as approved by the Board of Directors on 3rd April 2025. Outcome of Board meeting held on 3rd April 2024 is attached herewith. (As Per BSE Announcement Dated on: 03/04/2025)
10-Feb-2025	27-Feb-2025	Quarterly Results	INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve the unaudited financial results (Standalone and Consolidated) of the company for the quarter and nine months ended 31-12-2024 and any other business. Intimation of adjournment of Board meeting and closure of trading window (As Per Bse Announcement Dated on 14.02.2025) INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/02/2025 ,inter alia, to consider and approve the unaudited financial results (Standalone and Consolidated) of the company for the quarter and nine months ended 31-12-2024 and any other business. A Board meeting for considering the said financial results was conducted on 14-02-2025 for which due intimation was given on 10-02-2025. That Board meeting could not consider said financial results since the financial statements of the material subsidiaries could not be consolidated due to unforeseen circumstances. The said financial results is being considered at an adjourned meeting to be held on 27-02-2024. While giving this intimation to Stock Exchange there is no provision to choose adjourned meeting in the given descriptions hence we have chosen Board meeting rescheduled in the description. Therefore we request you to kindly take note of the adjourned Board meeting. (As Per Bse Announcement Dated on 26.02.2025) Financial results and Limited review report for the quarter and nine months ended 31, December 2024 (As Per Bse Announcement Dated on 27.02.2025) Clarification letter on delay in submission of unaudited financial results for the quarter and nine months ended December 31, 2024 is attached. (As Per Bse Announcement Dated on 28.02.2025)
11-Nov-2024	14-Nov-2024	Quarterly Results	INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended 30th September 2024 and Rights issue of equity shares Results (As Per BSE Announcement Dated on 15.11.2024)
08-Aug-2024	14-Aug-2024	Quarterly Results	INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve The Meeting of the Board of Director of the Company is Scheduled on 14-08-2024 inter-alia to consider and approve the Standalone and Consolidated unaudited financial results for the quarter ended June 30 2024. Outcome of the Board Meeting held on 14-08-2024 is Attached. (As Per Bse Announcement Dated on 14.08.2024)
24-Jul-2024	27-Jul-2024	Investments	INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2024 inter alia to consider and approve the following items of business: 1. To approve the increase and reclassification of authorized share capital of the company subject to the approval of the shareholders. 2. To increase the limit of investment in the total paid up capital of the Company by foreign portfolio investors foreign institutional investors and non-resident Indians subject to the approval of the shareholders. 3. To consider and approve material related party transactions between the Company and subsidiaries subject to the approval of the shareholders. 4. To consider and approve Directors report and annexures thereon. 5. To take note of the Secretarial audit report 6. To fix the date time venue and mode of 32ndAnnual General Meeting of the Company and approve the draft Notice for convening the said General Meeting. 7. To appoint the Scrutinizer for 32ndAnnual General Meeting of the Company. 8. Other business matters. Please find attached outcome of Board meeting pursuant to Regulation 30 of SEBI LODR Regulations, 2015 (As Per BSE Announcement dated on 27.07.2024)
23-May-2024	30-May-2024	Accounts	INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31 2024 along with audit report of Statutory auditors and other business matters. Approved the audited financial results along with audited report for the quarter and year ended 31 March 2024. (As Per BSE Announcement Dated on 31.05.2024) Please find attached updates. (As Per BSE Announcement dated on 01.07.2024)
04-Feb-2024	10-Feb-2024	Quarterly Results	INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve INDRAYANI BIOTECH LIMITED has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter & nine months ended December 31 2023 along with the Limited Review Report of Statutory Auditor and any other business with the permission of the Chair. Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, the Board of Directors at their meeting held on today, i.e., 10-02-2024 has approved the unaudited financial results for the quarter and nine months ended December 31, 2023. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, the Board of Directors at their meeting held today, i.e., 10-02-2024, has approved the appointment of V.Santhanakrishnan as a Company Secretary in Dindigul Farm Product Limited, a material subsidiary of the Company and necessary disclosure is provided as annexure. (As Per BSE Announcement dated on 10.02.2024)
06-Jan-2024	10-Jan-2024	Conversion	INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/01/2024 inter alia to consider and approve To consider the proposal for increasing the authorized share capital subject to the shareholders approval. To consider and approve the conversion of unsecured loans into equity under Section 62(3) of the Companies Act 2013 subject to the shareholders approval. Any other business with the permission of the Chair. INDRAYANI BIOTECH LTD. has informed BSE about Board Meeting to be held on 10 Jan 2024 to consider Increase in authorised capital / Other business. The Board of Directors of the Company, at their meeting held on today, January 10, 2024, have inter-alia considered and approved the following matters: Recommendations to get approval from shareholders of the Company through postal ballot for the below mentioned items: To consider and to grant approval to increase authorised share capital To consider and to grant approval to amend the Articles of Association of the Company To consider and approve an amendment in the terms and conditions of existing unsecured loan arrangements availed from Mr. Kasiraman Sayee Sundar, Managing Director & M/s. Bougainvillea Investments Private Limited Took note of the resignation of Mr. Rajesh Kumar Sundarray (ACS membership number: A66744) as Company Secretary & Compliance Officer with effect from closing hours on January 10, 2024 and has appointed Mr. V Santhanakrishnan (ACS membership number: A54146) for the position of Company Secretary & Compliance Officer with effect from January 11, 2024. Pursuant to Regulation 30 of SEBI LODR, the Board of Directors of the Company, at their meeting held today, January 10, 2024, have inter-alia considered the following: Recommendations to get the approval from the shareholders of the Company through postal ballot for the following Increase of authorised share capital from Rs.46 crores to Rs.65 crores and consequential amendment to the capital clause of the memorandum of association of the Company Amendment in the Articles of association of the Company Summary of the proposed amendments in Memorandum and Articles of association of the Company are provided in the annexure. The Board of Directors at their meeting held today, January 10, 2024, has took note of the Resignation of Mr.Rajesh Kumar Sundarray (ICSI Membership no.A66744), from the office of the Company Secretary and Compliance officer with effect from closing hours of January 10, 2024. The Board of Directors at their meeting held today, January 10, 2024, has appointed Mr.V.Santhanakrishnan (ICSI Membership no.A54146), for the position of Company Secretary and Compliance officer with effect from January 11, 2024. (As Per BSE Announcement Dated on 10/01/2024) Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (As Per BSE Announcement Dated on 11/01/2024)
08-Nov-2023	14-Nov-2023	Quarterly Results	INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter & half year ended September 30 2023 along with the Limited Review Report of Statutory Auditor and any other business with the permission of the Chair. Board of Directors in its meeting held today i.e., on Tuesday, November 14, 2023, the Directors have inter-alia, approved the Unaudited Financial Results (Standalone and Consolidated) along with the Limited Review Report for the quarter & half year ended September 30, 2023. Pursuant to Regulation 33 of SEBI (LODR) Regulations 2015, the Board of directors in its Meeting held on today i.e. 14/11/2023 has approve the unaudited financial results for the quarter and half year ended on September 30, 2023. (As Per BSE Announcement Dated on 14/11/2023)
27-Oct-2023	01-Nov-2023	Dividend	INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2023 inter alia to consider and approve To recommend Payment of dividend on 12% Compulsorily Convertible Preference Shares. To consider and approve the allotment of Equity shares by conversion of Compulsorily Convertible Preference Shares subject to lock in period of 6 months. To consider and approve the conversion of Warrants into Equity Shares subject to lock in period of 6 months. Any other matter with the permission of the chair.
29-Aug-2023	29-Aug-2023	AGM	Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the Outcome of the Board Meeting held on August 29, 2023.
05-Aug-2023	11-Aug-2023	Quarterly Results	INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results along with limited review by the Statutory Auditors of the Company for the quarter ended June 30 2023 We wish to inform that at the meeting of Board of Directors held today i.e., on Friday, August 11, 2023, the Directors have inter-alia, approved the following: 1. Approved the Unaudited Financial Results (Standalone and Consolidated) with the Limited Review Report for the quarter ended June 30, 2023 (Q1) pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. Re-appointment of Mr. Krishnamurthi Ravichandran, Practicing Company Secretary as the Secretarial Auditor of the company for the Financial Year 2023-24. 3. Appointment of Mr. Kanumuru Rajesh as an Internal Auditor of the Company for the Financial Year 2023-24. Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we wish to inform you that the Board of Directors of the company at the board meeting held on Friday, August 11, 2023 has re-appointed Mr. Krishnamurthi Ravichandran, Practicing Company Secretary as the Secretarial Auditor of the company for the FY 2023-23 and appointed Mr. Kanumuru Rajesh as an Internal Auditor of the company for the FY 2023-24. (As Per BSE Announcement dated on 11.08.2023)
07-Jun-2023	14-Jun-2023	Accounts	INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/06/2023 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to intimate that in accordance with Regulation 3(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 meeting of the Board of Directors will be held on Wednesday 14th June 2023 inter alia to consider and approve the following: 1. The Audited Financial Results (Standalone and Consolidated) for the Quarter and year ended 31st March 2023 along with the Audit report of Statutory Auditor. 2. Any other business with the permission of the Chair. Audited financial results (standalone and consolidated) of the Company for the quarter and year ended March 31, 2023, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. Audited financial results (standalone and consolidated) of the Company for the quarter and year ended March 31, 2023, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. (As Per BSE Announcement Dated on 15.06.2023) Revised Audited financial results (standalone and consolidated) of the Company for the quarter and year ended March 31, 2023, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. (As per BSE Announcement Dated on 17/06/2023)
22-May-2023	30-May-2023	Accounts	INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to intimate that in accordance with Regulation 33(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 meeting of the Board of Directors will be held on Tuesday 30th May 2023 inter alia to consider and approve the following: ? The Audited Financial Results (Standalone and Consolidated) for the Quarter and year ended 31st March 2023 along with the Audit report of Statutory Auditor. ? Any other business with the permission of the Chair.
11-May-2023	11-May-2023	Change in Other Executives	1. Appointment of Mr. Rajesh Kumar Sundarray (M.N.: 66744) as new Company Secretary cum Compliance Officer with effect from 11.05.2023. The required details pursuant to listing regulation is herewith enclosed as Annexure- I. 2. Acceptance of resignation of Ms. Vennila Vijayaragavan (ACS No: 67227) from the office of Company Secretary due to her inability to continue after Maternity leave with effect from Today, 11th May 2023. Consequently, the office of Compliance officer of the Company, Ms. Mamtha Madesh appointed on behalf of the Company Secretary during the tenure of her absence on Maternity leave (Ref: BSE announcement dated 10-12-2022) shall also be ceased with effect from the resignation of Company Secretary i.e. Today, 11th May 2023. With reference to the above captioned subject and pursuant to Regulation 30 SEBI LODR Regulations, 2015, this is to inform you that Mr.Rajesh Kumar Sundarray (ACS No: 66744) has been appointed as Company Secretary & Compliance Officer of the Company with effect from Thursday, 11th May 2023 pursuant to Section 203 of the Companies Act, 2013 and Regulation 6(1) of SEBI LODR Requirements, 2015 on recommendation of the Nomination and Remuneration Committee and the same has been approved in the Board meeting held on Thursday, 11th May 2023.

1 2 3

LOGIN HERE

Indrayani Biotech Ltd

Board Meeting